Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Clinical Nephrology
You have accessRestricted Access

Association between Renal Insufficiency and Inducible Ischemia in Patients with Coronary Artery Disease: The Heart and Soul Study

Joachim H. Ix, Michael G. Shlipak, Haiying H. Liu, Nelson B. Schiller and Mary A. Whooley
JASN December 2003, 14 (12) 3233-3238; DOI: https://doi.org/10.1097/01.ASN.0000095642.25603.7A
Joachim H. Ix
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael G. Shlipak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haiying H. Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nelson B. Schiller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary A. Whooley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

This article has a correction. Please see:

  • Correction - February 01, 2004

Abstract

ABSTRACT. Chronic renal insufficiency (CRI) is a predictor of stroke, cardiovascular, and all-cause mortality, but the mechanisms responsible for these associations are unclear. Whether CRI was associated with severity of coronary artery disease (CAD) as measured by exercise stress echocardiography among outpatients with stable CAD was evaluated. This study is a cross-sectional analysis of the Heart and Soul study, a prospective cohort of patients with known CAD. Renal function was assessed by 24-h urine collection, and CRI was defined as measured creatinine clearance ≤60 ml/min. Exercise stress echocardiography was used to identify inducible ischemia, defined as any wall motion abnormality seen at stress but not at rest. Logistic regression was used to evaluate the association of CRI with exercise-induced ischemia after adjustment for cardiovascular risk factors. Participants with CRI composed 97 (23%) of the 431 participants and were characterized by older age, worse CAD, lower ejection fraction, greater left ventricular mass and higher C-reactive protein values. The prevalence of exercise-induced ischemia was also substantially greater in the participants with CRI (42% versus 23%; odds ratio [OR], 2.3; 95% confidence interval [CI], 1.4 to 3.8; P < 0.001). This association was minimally changed by adjustment for traditional cardiovascular risk factors and coronary disease history (OR, 2.0; 95% CI, 1.3 to 3.3; P < 0.01) and remained strong even after adjustment for C-reactive protein (OR, 2.3; 95% CI, 1.0 to 5.1; P = 0.04). CRI is strongly associated with exercise-induced ischemia in patients with CAD. The greater severity of atherosclerotic disease observed in patients with CRI may in part explain the association of CRI with increased cardiovascular risk among individuals with CAD.

Mild to moderate chronic renal insufficiency (CRI) is estimated to affect more than one fourth of people aged 65 and older in the United States (1) and is an independent predictor of stroke (2,3⇓), cardiovascular (2–6⇓⇓⇓⇓), and all-cause mortality (2–5,7,8⇓⇓⇓⇓⇓). In people with established coronary artery disease (CAD), CRI predicts recurrent events as strongly as other established cardiovascular risk factors such as diabetes and elevated BP (6). Whether the cardiovascular risk in the setting of CRI is due to increased atherosclerotic burden, higher risk of plaque rupture as a result of inflammation (9), or other mechanisms is unknown.

One method that can be used to determine the severity of CAD is exercise treadmill testing with stress echocardiography (10–12⇓⇓). To evaluate the association of CRI and inducible ischemia, we measured creatinine clearance (CrCl) and performed stress echocardiography in a cross-sectional study of 431 participants enrolled in the Heart and Soul study. We hypothesized that CRI would be associated with inducible ischemia independent of hypertension, diabetes, or other traditional cardiovascular risk factors. Because inflammatory biomarkers are known to be elevated in people with CRI, we also sought to determine whether inflammation was a mediator of this association (9).

Materials and Methods

Participants

The Heart and Soul study is a prospective cohort designed to investigate the influence of psychosocial factors on CAD progression. Methods have been described previously (13,14⇓). Participants were recruited from outpatient clinics in the San Francisco Bay Area if they met one of the following inclusion criteria: (1) history of myocardial infarction, (2) angiographic evidence of >50% stenosis in one or more coronary vessels, (3) evidence of exercise-induced ischemia by treadmill or nuclear testing, (4) history of coronary revascularization, or (5) documented diagnosis of CAD by an internist or cardiologist. Participants were excluded when they were not able to walk one block or were likely to move out of the area within 3 yr. The study protocol was approved by the appropriate Institutional Review Boards, and all participants provided written, informed consent.

Between September 2000 and March 2002, 564 participants were enrolled. We excluded those who did not have 24-h urine collection data (n = 7) or who were unable to perform at least 3 min of exercise by the Bruce protocol (n = 126). This was done to ensure that a minimum level of exertion was attained to assess stress-induced ischemia. The study population therefore includes 431 participants.

Measurements

Primary Predictor Variable.

Presence or absence of CRI was determined by 24-h urine collection for all participants. At the intake appointment, participants were provided with a 3-L collection jug and instructed to save all urine between the end of their intake appointment and the time when a researcher recovered the urine. Participants were instructed to keep the urine collections refrigerated at all times. Research personnel arrived at the participants’ home 24 h after their inception appointments to ensure accurately timed specimens. At that time, participants were asked about the time of their first and last voids. When more than 1 h had passed since their last void, participants were instructed to void at that time to complete the collection. All participants were asked whether they were able to collect all urine or whether some fraction had been inadvertently discarded. When the sample was reported to be incomplete, participants were asked to repeat the collection, and research personnel returned 24 h later to re-collect the urine. When the 24-h urine volume was <1 L, participants were asked to repeat the collection to ensure an adequately collected specimen. Similarly, when the 3-L collection jug was completely full, participants were given two new jugs and asked to repeat the collection to ensure that no urine was inadvertently discarded. When participants were unable to collect all urine for any reason or had urinary incontinence, their samples were deemed inadequate and no data were recorded for these participants. CrCl was calculated using the following formula: urine creatinine (mg/dl) * 24-h urine volume (dl)/serum creatinine (mg/dl) * 1440 (min/d). A priori, we defined CRI as measured CrCl of ≤60 ml/min (15).

Secondary Predictor Variables.

Age; race; smoking status; and medical history of diabetes, hypertension, myocardial infarction, and coronary revascularization were determined by self-report. We measured weight and height and calculated body mass index (kg/m2). Participants were instructed to bring their medication bottles to the study appointment, and study personnel recorded all current medications. After a 12-h fast, serum samples were obtained for measurement of creatinine, total cholesterol, HDL, LDL, albumin, and hematocrit.

To explore the role of inflammation as a potential mediator of the association between CRI and ischemia, we measured C-reactive protein (CRP) in 118 participants with exercise-induced ischemia and in a random sample of 111 participants without ischemia. We used the Roche Integra assay, an enhanced immunoturbidimetric assay that uses latex particles that are coated with monoclonal anti-CRP antibodies to measure CRP with high sensitivity. The assay has been standardized against the World Health Organization reference and has been compared with the Dade nephelometric method with a correlation coefficient of 0.997. The interassay coefficient of variation is 3.2%, and the lowest detectable measurement with this assay is 0.025 mg/dl. For this analysis, we considered high CRP levels as >0.38 mg/dl, based on cut points used in previous studies (13,16⇓).

Outcome Variable.

The primary outcome was the presence or absence of exercise-induced ischemia (17). We performed a symptom-limited graded exercise treadmill test according to the Standard Bruce Protocol for all participants at their inception appointment. Participants were asked to walk on a treadmill beginning at a workload of 20 to 30 W and increased by 20 to 30 W every 3 min until they reached dyspnea, symptom-limited fatigue, chest discomfort, or electrocardiographic changes suggestive of ischemia. Continuous electrocardiographic monitoring with 12-lead electrocardiography was performed throughout exercise.

Doppler echocardiography just before exercise was used to obtain a complete resting two-dimensional echocardiogram, including imaging and Doppler in all standard views and subcostal imaging of the inferior vena cava. Standard two-dimensional parasternal short-axis and apical two- and four-chamber views obtained during held inspiration were planimetered using a computerized digitization system (Tom Tec Corporation, Boulder, CO) to determine left ventricular volume, ejection fraction, stroke volume, cardiac output, and mass. At peak exercise, apical two- and four-chamber views were obtained to detect the development of right or left ventricular dilation or wall motion abnormalities. We defined exercise-induced ischemia as the presence of new wall motion abnormalities not visualized on the baseline rest echocardiogram. An experienced echocardiographer who was without knowledge of electrocardiograms, renal function status, or additional diagnostic tests analyzed all echocardiograms.

Statistical Analyses

Differences in baseline characteristics between participants with and without CRI were compared using χ2 tests for dichotomous variables and t tests (or nonparametric equivalent) for continuous variables. We used forward stepwise multivariate logistic regression to determine the independent association of CRI with exercise-induced ischemia. Certain variables were forced into the multivariate model because of their strong association with cardiovascular or renal disease in previous studies (age, diabetes, hypertension, angiotensin-converting enzyme inhibitor use, HDL, and LDL). Other candidate variables that were associated with exercise-induced ischemia at P < 0.2 were also retained in our multivariate models. Candidate variables included gender; race; history of congestive heart failure, myocardial infarction, angioplasty, coronary bypass surgery, angina, or smoking status; ejection fraction, left ventricular mass, body mass index, serum levels of total cholesterol, triglycerides, hematocrit, and albumin; and medical therapy with HMG-CoA reductase inhibitors, aspirin, and β blockers. Finally, to determine whether inflammation attenuates the association between CRI and ischemia, we performed further multivariate adjustment for CRP in the subset of participants for whom CRP values were available. Analyses were performed using the Statistical Analysis Software (version 8; SAS Institute, Inc, Cary, NC).

Results

Baseline Characteristics

Among the 431 participants, 97 (23%) had CRI. Of these, 68 participants had CrCl between 40 and 60 ml/min, 27 participants had CrCl between 20 and 40 ml/min, and two participants had CrCl <20 ml/min. Compared with participants who had normal renal function, those who had CRI were older and more often had a history of myocardial infarction or coronary artery bypass surgery (Table 1). They had a lower mean ejection fraction and greater left ventricular mass. Participants with CRI also had lower body mass index, hematocrit, and albumin levels and higher CRP measurements. They were more likely to be taking statins and less likely to be taking aspirin.

View this table:
  • View inline
  • View popup

Table 1. Baseline characteristics of the 431 participants by presence of chronic renal insufficiency

Association of Renal Insufficiency and Exercise-Induced Ischemia

CRI was strongly associated with exercise-induced ischemia (Figure 1, Table 2). Among participants with CRI, 42% had inducible ischemia, compared with 23% of those with normal renal function (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.4 to 3.8; P < 0.01). After multivariate adjustment, CRI remained strongly associated with exercise-induced ischemia (OR, 2.0; 95% CI, 1.2 to 3.3; P = 0.01). After further adjustment for CRP, the adjusted association was essentially unchanged (OR, 2.3; 95% CI, 1.0 to 5.1).

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Percentage of participants with inducible ischemia by subgroup of measured creatinine clearance. The prevalence of inducible ischemia increased significantly as creatinine clearance decreased (P < 0.001 for trend).

View this table:
  • View inline
  • View popup

Table 2. Univariate and multivariate association of chronic renal insufficiency with exercise-induced ischemia

Test for Interaction

In stratified analysis, we observed similar associations between CRI and inducible ischemia in participants with and without diabetes (P = 0.67 for interaction). The OR for CRI as a predictor of exercise-induced ischemia was 2.7 (95% CI, 1.1 to 7.1) in participants with diabetes and 2.1 (95% CI, 1.2 to 3.7) in those without diabetes. Similarly, there was no interaction with hypertension. The odds of CRI as a predictor of ischemia was 2.3 (95% CI, 1.2 to 4.3) for participants with hypertension and 1.7 (0.6 to 4.6) in those without hypertension (P 0.93 for interaction). Likewise, we did not observe any significant interactions between CRI and levels of hematocrit (P = 0.31 for interaction), CRI and congestive heart failure (P = 0.30 for interaction), or CRI and elevated CRP (P = 0.25 for interaction).

Discussion

Our analysis demonstrates that CRI is strongly associated with exercise-induced ischemia as assessed by stress echocardiography in participants with established CAD. The association was substantial and independent of other known risk factors such as hypertension or diabetes. As stress echocardiograms have been shown to predict CAD risk and atherosclerotic burden (10–12⇓⇓), our findings indicate that even among participants with known CAD, the presence of CRI is associated with increased atherosclerosis. These results add to the growing body of evidence suggesting that CRI predicts high cardiovascular risk in individuals with established CAD (4–6⇓⇓).

The increased cardiovascular risk for individuals with CRI was explained only in part by their increased prevalence and severity of diabetes and hypertension. Other renal-specific mechanisms likely contribute to the increased risk and are poorly understood. The proinflammatory state described in CRI has been proposed as one potential mediator (9). The current analysis, along with previous work from our group (9), establishes that CRP levels are elevated in individuals with CRI. However, CRP did not seem to substantially mediate the association of CRI with inducible ischemia in this study. Multiple other factors have also been proposed, including elevated levels of fibrinogen (9) and homocysteine (18), altered lipid metabolism (19–21⇓⇓), and markers of increased coagulability and fibrinolysis (9). Their relative contributions should be addressed in future studies.

The findings of our study indicate that individuals with stable CAD and CRI may benefit from more aggressive cardiovascular screening and prevention. We found that individuals at particularly high risk can be identified with stress echocardiography, a noninvasive test readily available at most medical centers. Individuals with inducible ischemia might benefit from more intensive medical therapy for established and modifiable cardiovascular risk factors. The importance of such therapy is reinforced by multiple previous studies that have shown that use of cardioprotective medications is lower in individuals with CRI than in those with normal renal function (7,22⇓).

A particular strength of our study is the use of a direct measure of renal function with 24-h urine collections. Most previous studies have relied on one-time measurements of serum creatinine to estimate CrCl. We believe that our study therefore more accurately quantifies the association of CRI with inducible ischemia and CAD risk. However, several limitations should also be considered in interpreting our results. Although our findings demonstrate that CRI is associated with exercise-induced ischemia, we cannot determine the direction of the association because of the cross-sectional design. In addition, although our hypothesis is that CRI leads to accelerated atherosclerosis and coronary disease instability, it is possible that an unmeasured risk factor was a predictor of both CRI and exercise-induced ischemia. However, to explain the twofold odds of the observed association, any lurking confounder would need to be highly prevalent in the cohort and strongly associated with both CRI and inducible ischemia. Furthermore, our study participants were mostly men, and our results therefore may not be generalizable to women. Finally, our study did not include anatomic measures of coronary disease; thus, we were not able to determine whether CRI is associated with ischemia because of greater anatomic disease burden or through other mechanisms (23,24,25).

In summary, we found that among individuals with CAD, the presence of CRI is strongly associated with exercise-induced ischemia. We believe that all patients with CRI merit aggressive cardiovascular risk factor management. Those with exercise-induced ischemia are likely at highest risk and might be considered for further diagnostic investigation. Finally, although we found individuals with CRI to have higher CRP values, the association of CRI with inducible ischemia did not seem to be mediated solely through inflammation.

  • © 2003 American Society of Nephrology

References

  1. ↵
    Clase CM, Garg AX, Kiberd BA: Prevalence of low glomerular filtration in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13: 1338–1349, 2002
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555–562, 2002
    OpenUrlCrossRefPubMed
  3. ↵
    Shulman NB, Ford CE, Hall WD, et al: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13 [5 Suppl]: I80–I93, 1989
  4. ↵
    Ruilope LM, Salvetti A, Jamerson K, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12: 218–225, 2001
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629–636, 2001
    OpenUrlCrossRefPubMed
  6. ↵
    Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13: 745–753, 2002
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Shlipak MG, Simon JA, Grady D, Lin F, Wenger NK, Furberg CD; Heart and Estrogen/progestin Replacement Study (HERS) Investigators: Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38: 705–711, 2001
    OpenUrlCrossRefPubMed
  8. ↵
    Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41: 1364–1372, 2003
    OpenUrlCrossRefPubMed
  9. ↵
    Wolfe RA, Port FK, Webb RL, et al: Excerpts from the United States Renal Data System, 1998. Annual data report: V. Patient mortality and survival. Am J Kidney Dis 32 [Suppl 1]: 269–280, 1998
    OpenUrl
  10. ↵
    Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836–843, 2000
    OpenUrlCrossRefPubMed
  11. ↵
    Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87–92, 2003
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Cortigiani L, Eugenio P, Coletta C, Chiarella F, Mathias W, Gandolfo N, De Alcantara M, Mazzoni V, Gensini GF, Landi P; Echo Persantine International Cooperative (EPIC) Study Group; Echo Dobutamine International Cooperative (EDIC) Study Group: Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am Heart J 141: 621–629, 2001
    OpenUrlCrossRefPubMed
  13. ↵
    Olmos LI, Dekik H, Gordon R, Dunn JK, Verani MS, Quinones MA, Zoghbi WA: Long-term prognostic value of exercise echocardiography compared with exercise 201Tl ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 98: 2679–2686, 1998
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Arruda AM, McCully RB, Oh JK, Mahoney DW, Seward JB, Pellikka PA: Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery. Am J Cardiol 87: 1069–1073, 2001
    OpenUrlCrossRefPubMed
  15. ↵
    K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39: S1–S246, 2002
    OpenUrlCrossRefPubMed
  16. ↵
    Chauveau P, Chadefaux B, Coude M, et al: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 43: S72–S77, 1993
    OpenUrl
  17. ↵
    Appel G: Lipid abnormalities in renal disease. Kidney Int 39: 169–183, 1991
    OpenUrlPubMed
  18. ↵
    Attman P, Samuelsson O, Alaupovic P: Lipoprotein metabolism and renal failure. Am J Kidney Dis 21: 573–592, 1993
    OpenUrlPubMed
  19. ↵
    Kimak E, Solski J, Janicka L, Zagojska M: Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency. Int Urol Nephrol 31: 263–267, 1999
    OpenUrlCrossRefPubMed
  20. ↵
    Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA: Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 37: 484–489, 2001
    OpenUrlPubMed
  21. ↵
    Rifai N, Ridker PM: Proposed cardiovascular risk assessment algorithm using high sensitivity C-reactive protein and lipid screening. Clin Chem 47: 28–30, 2001
    OpenUrlFREE Full Text
  22. ↵
    Beattie MS, Shlipak MG, Liu H, Browner WS, Schiller NB, Whooley MA: CRP and ischemia in users and nonusers of beta blockers and statins: Data from The Heart and Soul Study. Circulation 107: 245–250, 2003
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 14 (12)
Journal of the American Society of Nephrology
Vol. 14, Issue 12
1 Dec 2003
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Association between Renal Insufficiency and Inducible Ischemia in Patients with Coronary Artery Disease: The Heart and Soul Study
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Association between Renal Insufficiency and Inducible Ischemia in Patients with Coronary Artery Disease: The Heart and Soul Study
Joachim H. Ix, Michael G. Shlipak, Haiying H. Liu, Nelson B. Schiller, Mary A. Whooley
JASN Dec 2003, 14 (12) 3233-3238; DOI: 10.1097/01.ASN.0000095642.25603.7A

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Association between Renal Insufficiency and Inducible Ischemia in Patients with Coronary Artery Disease: The Heart and Soul Study
Joachim H. Ix, Michael G. Shlipak, Haiying H. Liu, Nelson B. Schiller, Mary A. Whooley
JASN Dec 2003, 14 (12) 3233-3238; DOI: 10.1097/01.ASN.0000095642.25603.7A
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
  • Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors
  • IgACE: A Placebo-Controlled, Randomized Trial of Angiotensin-Converting Enzyme Inhibitors in Children and Young People with IgA Nephropathy and Moderate Proteinuria
Show more Clinical Nephrology

Cited By...

  • Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function - the Tromso study
  • Comparison of Cardiovascular Prognosis by 3 Serum Cystatin C Methods in the Heart and Soul Study
  • Impact of Age and Overt Proteinuria on Outcomes of Stage 3 to 5 Chronic Kidney Disease in a Referred Cohort
  • Urinary Creatinine Excretion Rate and Mortality in Persons With Coronary Artery Disease: The Heart and Soul Study
  • Renal disease and acute coronary syndrome
  • Cystatin C and Cardiovascular Risk
  • Development of an Echocardiographic Risk-Stratification Index to Predict Heart Failure in Patients With Stable Coronary Artery Disease: The Heart and Soul Study
  • Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study
  • Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study
  • Increase in Creatinine and Cardiovascular Risk in Patients with Systolic Dysfunction after Myocardial Infarction
  • Association Between Human Fetuin-A and the Metabolic Syndrome: Data From the Heart and Soul Study
  • Google Scholar

Similar Articles

Related Articles

  • Correction
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire